Jay D. Rosenbaum’s CME Group CME Stock Holding History

Jay D. Rosenbaum’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,108	Closed	-$227K	–	60
2022 Q2	$227K	Hold	1,108	–	–	0.44%	57
2022 Q1	$264K	Hold	1,108	–	–	0.42%	52
2021 Q4	$253K	Buy	+1,108	New	+$244K	0.37%	59

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Jay D. Rosenbaum's CME Position: Q3 2022 in Review

Jay D. Rosenbaum sold out of CME Group (CME) in Q3 2022, closing a stake of 1,108 shares — an estimated $227K sold.

Jay D. Rosenbaum first reported a position in CME in Q4 2021 and held it in 3 quarters. The position peaked at $264K in Q1 2022. 1,145 funds tracked by Wall St. Rank hold CME as of Q3 2022.

Jay D. Rosenbaum reported no remaining CME Group position as of Q3 2022 after selling out during the quarter.
Jay D. Rosenbaum sold 1,108 CME Group shares in Q3 2022, an estimated $227K.
Jay D. Rosenbaum first reported a position in CME Group in Q4 2021 and held it in 3 quarters.
Jay D. Rosenbaum's CME Group position peaked at $264K in Q1 2022.
1,145 funds tracked by Wall St. Rank held CME Group as of Q3 2022.

Based on Jay D. Rosenbaum's 13F filing for Q3 2022, filed 10 Nov 2022.